We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

New findings show clinicians still order broad food allergy IgE panels despite false positives. More...
17 Nov 2026
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

New data show broad genomic sequencing improves survival and guides targeted therapy in advanced lung cancer. More...
17 Nov 2026
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

C2N Diagnostics announces that health care professionals can now order its FDA-cleared PrecivityAD2 blood test. More...
17 Nov 2026
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

A new p-tau217 blood test model with age and genetics estimates 5- and 10-year risk of cognitive impairment. More...
16 Nov 2026
Image: The cobas Mass Spec solution combines the high specificity, sensitivity, and accuracy of mass spectrometry with an automated, standardized workflow. (Photo courtesy of Roche)

FDA Authorization Adds Gabapentin Testing to Roche Mass Spectrometry Solution

Roche received FDA De Novo authorization for the cobas pro i 601 platform with the Ionify Gabapentin assay, components of its cobas Mass Spec solution. More...
16 Nov 2026
Image Credit: Shutterstock

Lung Cancer Atlas Reveals Cellular Patterns Associated With Patient Prognosis

An AI approach using single-cell RNA-seq maps lung tumors to predict outcomes and metastasis risk beyond staging. More...
16 Nov 2026
Image: At Hall 3, Stand D95, the company is highlighting integrated IVD solutions, recombinant QC materials, and calibrator raw materials for localized diagnostic production (Photo courtesy of Fapon)

Fapon Highlights Local Manufacturing Solutions and Recombinant QC Materials

Fapon is exhibiting its local manufacturing solutions and comprehensive in vitro diagnostics (IVD) portfolio at MEDICA 2026. More...
16 Nov 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Urinalysis Solution
UN-9000
Gold Member
Neonatal Heel Incision Device
Tenderfoot